Stocks and InvestingStocks and Investing
Wed, September 13, 2023
Tue, September 12, 2023
Mon, September 11, 2023
Fri, September 8, 2023

Jason Gerberry Maintained (TEVA) at Strong Buy with Increased Target to $13 on, Sep 8th, 2023


Published on 2024-10-28 06:19:14 - WOPRAI, Jason Gerberry
  Print publication without navigation


Jason Gerberry of B of A Securities, Maintained "Teva Pharmaceutical Industries Limited" (TEVA) at Strong Buy with Increased Target from $12 to $13 on, Sep 8th, 2023.

Jason has made no other calls on TEVA in the last 4 months.



There are 3 other peers that have a rating on TEVA. Out of the 3 peers that are also analyzing TEVA, 2 agree with Jason's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Ashwani Verma of "UBS" Upgraded from Strong Sell to Hold and Increased Target to $8 on, Thursday, July 6th, 2023
  • Thibault Boutherin of "Morgan Stanley" Initiated at Hold and Held Target at $10 on, Thursday, May 25th, 2023


This is the rating of the analyst that currently disagrees with Jason


  • Umer Raffat of "Evercore ISI Group" Upgraded from Hold to Buy on, Thursday, May 18th, 2023